Skip to main content
. Author manuscript; available in PMC: 2016 Apr 12.
Published in final edited form as: Mol Cancer Res. 2015 Aug 6;14(1):3–13. doi: 10.1158/1541-7786.MCR-15-0189

Table 1.

Tissue representation of cell lines in large in vitro pharmacogenomics databases

Malignancy CCLE GDSC CTRP NCI-60 Unique
Bladder 28 18 5 0 29
Bone 29 31 1 0 53
Breast 60 43 1 5 64
Cervix 0 12 0 0 12
Colon 63 35 37 7 70
Endometrium 28 10 11 0 29
Head and neck 35 23 2 0 44
Hematopoietic and lymphoid 181 113 24 6 227
Kidney 36 22 2 8 48
Liver 36 14 4 0 41
Lung 187 141 91 9 226
Nervous system 86 79 3 6 126
Osephagus 27 23 3 0 29
Ovary 52 20 26 7 57
Pancreas 46 17 10 0 47
Prostate 8 5 1 2 9
Skin 62 45 9 10 79
Soft tissue 21 17 3 0 28
Stomach 38 18 6 0 44
Testis 0 2 0 0 2
Thyroid 12 12 0 0 16
Other 11 7 3 0 20
Total # of cell lines 1,046 707 242 60 1300
Total # of agents tested 24 139 185 −50,000

NOTE: The number of cell lines across all tissues is listed for each database along with the total number of agents tested. The final column identifies the number of unique cell lines across all four datasets for each cancer type.